Women's Healthcare
Specialist in women's health
Contraception
Bayer Schering Pharma is the global market leader in the field of hormonal contraception. Our wide range of innovative contraceptives enable women to make a conscious decision on the size of their families and to choose what is best for them from several options. These include low-dose oral contraceptives with additional health benefits, e.g. the first contraceptive “Pill” to be approved in many countries for three indications: oral contraception, moderate acne, and the emotional and physical symptoms of premenstrual dysphoric disorder (PMDD, a severe form of premenstrual syndrome). A further product is the first oral contraceptive to offer the same estrogen as the kind produced by a woman’s body.
Menopausal complaints
Menopausal symptoms can greatly impair a woman’s quality of life. Bayer Schering Pharma offers women products which alleviate symptoms quickly and effectively, thus helping them to manage the menopause with a minimum of problems.
Gynecological therapies
In the field of gynecological therapies, Bayer Schering Pharma is developing new treatment options for diseases with high unmet medical need, e.g. endometriosis (growth in the mucous membrane of the uterus outside the uterine cavity) and myomas (benign tumors of the uterus musculature). A specific therapy for endometriosis has recently been approved in Europe.
